title: TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis.
abstract: In 2007, the Tokyo Guidelines for the management of acute cholangitis and cholecystitis (TG07) were first published in the Journal of Hepato-Biliary-Pancreatic Surgery. The fundamental policy of TG07 was to achieve the objectives of TG07 through the development of consensus among specialists in this field throughout the world. Considering such a situation, validation and feedback from the clinicians' viewpoints were indispensable. What had been pointed out from clinical practice was the low diagnostic sensitivity of TG07 for acute cholangitis and the presence of divergence between severity assessment and clinical judgment for acute cholangitis. In June 2010, we set up the Tokyo Guidelines Revision Committee for the revision of TG07 (TGRC) and started the validation of TG07. We also set up new diagnostic criteria and severity assessment criteria by retrospectively analyzing cases of acute cholangitis and cholecystitis, including cases of non-inflammatory biliary disease, collected from multiple institutions. TGRC held meetings a total of 35 times as well as international email exchanges with co-authors abroad. On June 9 and September 6, 2011, and on April 11, 2012, we held three International Meetings for the Clinical Assessment and Revision of Tokyo Guidelines. Through these meetings, the final draft of the updated Tokyo Guidelines (TG13) was prepared on the basis of the evidence from retrospective multi-center analyses. To be specific, discussion took place involving the revised new diagnostic criteria, and the new severity assessment criteria, new flowcharts of the management of acute cholangitis and cholecystitis, recommended medical care for which new evidence had been added, new recommendations for gallbladder drainage and antimicrobial therapy, and the role of surgical intervention. Management bundles for acute cholangitis and cholecystitis were introduced for effective dissemination with the level of evidence and the grade of recommendations. GRADE systems were utilized to provide the level of evidence and the grade of recommendations. TG13 improved the diagnostic sensitivity for acute cholangitis and cholecystitis, and presented criteria with extremely low false positive rates adapted for clinical practice. Furthermore, severity assessment criteria adapted for clinical use, flowcharts, and many new diagnostic and therapeutic modalities were presented. The bundles for the management of acute cholangitis and cholecystitis are presented in a separate section in TG13. Free full-text articles and a mobile application of TG13 are available via http://www.jshbps.jp/en/guideline/tg13.html.
authors.affiliation: Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan. takada@med.teikyo-u.ac.jp
authors.forename: Tadahiro
authors.initials: T
authors.lastname: Takada
authors.forename: Steven M
authors.initials: SM
authors.lastname: Strasberg
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Solomkin
authors.forename: Henry A
authors.initials: HA
authors.lastname: Pitt
authors.forename: Harumi
authors.initials: H
authors.lastname: Gomi
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yoshida
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Mayumi
authors.forename: Fumihiko
authors.initials: F
authors.lastname: Miura
authors.forename: Dirk J
authors.initials: DJ
authors.lastname: Gouma
authors.forename: O James
authors.initials: OJ
authors.lastname: Garden
authors.forename: Markus W
authors.initials: MW
authors.lastname: Büchler
authors.forename: Seiki
authors.initials: S
authors.lastname: Kiriyama
authors.forename: Masamichi
authors.initials: M
authors.lastname: Yokoe
authors.forename: Yasutoshi
authors.initials: Y
authors.lastname: Kimura
authors.forename: Toshio
authors.initials: T
authors.lastname: Tsuyuguchi
authors.forename: Takao
authors.initials: T
authors.lastname: Itoi
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Gabata
authors.forename: Ryota
authors.initials: R
authors.lastname: Higuchi
authors.forename: Kohji
authors.initials: K
authors.lastname: Okamoto
authors.forename: Jiro
authors.initials: J
authors.lastname: Hata
authors.forename: Atsuhiko
authors.initials: A
authors.lastname: Murata
authors.forename: Shinya
authors.initials: S
authors.lastname: Kusachi
authors.forename: John A
authors.initials: JA
authors.lastname: Windsor
authors.forename: Avinash N
authors.initials: AN
authors.lastname: Supe
authors.forename: SungGyu
authors.initials: S
authors.lastname: Lee
authors.forename: Xiao-Ping
authors.initials: XP
authors.lastname: Chen
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Yamashita
authors.forename: Koichi
authors.initials: K
authors.lastname: Hirata
authors.forename: Kazuo
authors.initials: K
authors.lastname: Inui
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Sumiyama
mesh_terms: D000208:Acute Disease; D015706:Bibliometrics; D002761:Cholangitis / Q000628:therapy*; D041881:Cholecystitis, Acute / Q000628:therapy*; D006801:Humans